G aseous transmitters are a growing family of regulatory molecules involved in multilevel regulation of physiologic and pathologic functions in mammalian tissues. 1 Although nitric oxide (NO) is the best characterized member of this family, it is increasingly recognized that carbon monoxide (CO) and hydrogen sulfide (H 2 S) might also function as gaseous mediators in mammalian cells. 1, 2 H 2 S synthesis from cysteine occurs naturally in a range of mammalian tissues principally through the activity of 2 pyridoxal-5=-phosphate-dependent enzymes, cystathionine ␥ lyase (CSE) and cystathionine ␤ synthetase (CBS), although alternative sources (eg, by activity of cysteine aminotransferase and/or 3-mercaptosulphurtransferase) cannot yet be discounted. [1] [2] [3] [4] In some tissues, CBS and CSE are both required for generation of H 2 S, whereas, in others, one enzyme suffices. CBS-derived H 2 S is a physiologically relevant neurotransmitter in the central nervous system in which exposure to this gaseous transmitter 1 results in activation of adenosine triphosphate (ATP)-sensitive K ϩ (K ATP ) channels. In the cardiovascular system, H 2 S, mostly derived from CSE, modulates endothelium-dependent and -independent vasodilation. 1, 5, 6 Highlighting the functional role of H 2 S, CBS deficiency leads to hyper-homocyst(e)inemia, a condition that includes elevated serum levels of homocysteine, homocystine, or homocysteine-mixed disulfides, and is associated with increased blood pressure and endothelial dysfunction. 7 In rodents, CBS/CSE deficiency induced by genetic-deletion 8, 9 or chronic treatment with DL-propargylglycine, an irreversible and selective inhibitor of CSE, 10 results in reduced nitric oxide (NO) bioactivity. This leads to severe endothelial dysfunction characterized by impaired aortic relaxation to acetylcholine and a paradoxical vasoconstriction of mesenteric microvessels in response to bradykinin. 9 Gastrointestinal injury is a common complication of nonsteroidal anti-inflammatory drugs (NSAIDs) and acetylsalicylic acid (ASA) therapy. 11 Owing to the inhibition of cyclooxygenase (COX) isoenzymes in the gastrointestinal tract, ASA and NSAIDs reduce the intrinsic ability of the gastric mucosa to resist injury induced by endogenous and exogenous agents. 11, 12 Thus, inhibition of generation of COX-1-and COX-2-derived eicosanoids (prostaglandin E 2 [PGE 2 ] and the lipoxin analogue, aspirin-triggered lipoxin) results in altered gastric mucosal blood flow and increased leukocyte-endothelial adhesive interactions in the gastric microcirculation, an essential step in the process of acute gastric injury caused by ASA/NSAIDs. [13] [14] [15] Human and animal studies have highlighted the role of gaseous mediators, particularly NO, in maintaining gastric mucosal integrity. 16, 17 Thus, by modulating expression/activity of adhesion molecules at the leukocyte-endothelium interface and by maintaining gastric mucosal blood flow, NO compensates for depressed generation of protective eicosanoids. 18 Whether or not the gastric mucosa has the ability to generate H 2 S and the regulatory functions exerted by this gaseous mediator in this tissue is unknown.
Materials and Methods

Materials
Aspirin; indomethacin; ketoprofen; diclofenac; lipopolysaccharide (LPS; Escherichia coli 0111:B4 serotype); sodium hydrogen sulfide (NaHS); L-cysteine, glibenclamide, a K ATP channel blocker; pinacidil, a K ATP opener; DL-propargylglycine; antiphosphoserine antibody; and all other reagents were purchased from Sigma Chemical Co. (St. Louis, MO). The stock solution of NaHS was freshly prepared by dissolving NaHS immediately before use. All tissue culture reagents, including minimal essential medium (MEM), fetal bovine serum (FBS), penicillin, and streptomycin, were obtained from Gibco (Milan, Italy). Filtered, deionized water was used for buffer preparation. Silver and sulphide ion selective electrodes were from ThermoOrion (Beverly, MA). The anti-human Sp1 antibody was from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA), and anti-ERK and anti-phospho-ERK antibody were obtained from New England Biolabs (Beverly, MA). The anti-CSE antibody was a generous gift of Dr. N. Nishi, Department of Endocrinology, Kagawa Medical School, Kagawa, Japan.
Acute Damage
All studies were approved by the animal study committees of the University of Perugia and the University of Calgary. Male Wistar rats (225-275 g) were obtained from Charles River Breeding Farms (Monza, Italy, or Montreal, Canada) and maintained on standard laboratory rat chow on a 12-hour light/dark cycle. Rats were deprived of food for 24 hours before being given one of the following orally: ASA (30 mg/kg), indomethacin (10 mg/kg), ketoprofen (30 mg/kg), ASA (30 mg/kg) plus celecoxib (100 mg/kg), or vehicle. [13] [14] [15] Rats were killed 3 hours later, and gastric mucosal damage was measured. To assess gastric mucosal damage, the lengths (in mm) of all lesions were measured with a digital calliper, and a "gastric damage score" was calculated for each stomach by summing these values. 13 This assessment was performed by an individual blinded to the treatments the rats had received. In addition, samples of the body region of the stomach were excised and processed, as described previously, 15 for measurement of myeloperoxidase (MPO) activity as an index of leukocyte accumulation in the tissue.
To investigate whether H 2 S administration could prevent the gastric injury caused by NSAIDs, rats were treated intraperitoneally with NaHS, as the H 2 S donor, at doses of 25, 50, 100, or 150 mol/kg or with vehicle, and 30 minutes later were given ASA orally at a dose of 50 mg/kg. [13] [14] [15] The rats were killed 3 hours later, and gastric mucosal damage and MPO activity were evaluated as described above. In these experiments, NaHS was used as the H 2 S donor for the following reasons: (1) NaHS dissociates to Na ϩ and HS Ϫ in solution, then HS Ϫ associates with H ϩ and produces H 2 S. At physiologic pH, Ӎone third of the H 2 S exists as the undissociated form (H 2 S), whereas the remaining two thirds exists as HS Ϫ at equilibrium with H 2 S; (2) the use of NaHS enables us to define the concentrations of H 2 S in solution more accurately and reproducibly than bubbling H 2 S gas; (3) the influence of Na ϩ ions (less than 1 mmol/L) is negligible; and (4) NaHS at concentrations used in the present study does not change the pH of the medium.
To investigate the role of endogenous H 2 S in modulating gastric mucosal resistance to damage induced by ASA and NSAIDs, rats were pretreated with DL-propargylglycine 5,10 at a dose of 10 mg/kg per day for 5 days and then administered ASA (50 mg/kg). The rats were killed 3 hours later, and gastric mucosal injury and MPO were assessed. In another set of experiments, we determined whether or not cysteine or N-acetylcysteine, which are known to release H 2 S after enzymatic degradation by CSE and CBS, would influence gastric resistance to ASA-induced damage. Rats were treated with cysteine (15 mg/kg) or N-acetylcysteine (15 mg/kg) prior to oral administraton of ASA (50 mg/kg). Three hours later, the extent of gastric damage was assessed, as described previously.
Finally, to determine whether K ATP channels are involved in the gastric protection afforded by H 2 S, 6 rats were pretreated intraperitoneally (IP) with NaHS (100 mol/kg) alone or in combination with glibenclamide (10 mg/kg), a K ATP channel blocker, or pinacidil, a K ATP channel opener, immediately prior to oral administration of ASA (50 mg/kg). Three hours later, the extent of mucosal injury and tissue MPO activity were assessed as described previously.
Gastric Mucosal Blood Flow
Rats were anesthetized with ketamine and pentobarbital sodium (50 mg/kg, IP), and body temperature was maintained at 37°C by means of a thermostatically regulated heating pad. Gastric blood flow was measured using a laserDoppler flowmeter (Perimed, Stockholm, Sweden). 19 The stomach was exposed by a midline laparotomy, opened by an incision along the greater curvature, and then pinned over a plexiglas platform and clamped. A "mucosal chamber" of 1.5 cm 2 gastric mucosa was prepared. 19 Throughout the experiment, the mucosa was bathed with 0.1 mmol/L HCl, maintained at 37°C by means of circulating warm water. Blood flow was measured after 30 minutes of equilibration and recorded continuously throughout the experiments from the mucosal side of the stomach with a laser probe placed 0.5-1 mm above the mucosal surface in the acidified solution. H 2 S (10 mg/kg) was administered IP at the end of the equilibration period. ASA (30 mg/kg) was administered orally 1 hour before the start of the experiment. The left carotid artery was cannulated and connected to a pressure transducer for mean arterial pressure (MAP) recording using a multichannel recorder (PowerLab PC; A.D. Instruments, Milford, MA). Four rats per group were used for these studies, and measurements were repeated at least 3 times.
Intravital Microscopy
Rats were anesthetized with pentobarbital sodium (60 mg/kg, IP), and cautery incisions were made along the abdominal region. A tracheotomy was performed to facilitate breathing. The rats were placed in a supine position, and a segment of the mesentery was exteriorized through the abdominal incision. The mesentery was carefully placed over an optically clear viewing pedestal that allowed for transillumination of a 2-cm 2 segment of tissue. All exposed tissue was covered with saline-soaked gauze to minimize dehydration. The temperature of the pedestal was kept at 37°C, and the mesentery was superfused with warmed bicarbonate-buffered saline (pH 7.4). An intravital microscope (Nikon L25/0.35) and a ϫ10 eyepiece were used to observe the mesenteric microcirculation. Postcapillary venules with diameters ranging from 20 to 40 m were selected for the study. A video camera mounted on the microscope (Panasonic digital 5000) projected the image onto a monitor, and the images were recorded for playback analysis using a videocassette recorder. Images of the mesenteric microcirculation were recorded for 15 minutes before aspirin administration (baseline), at the time of aspirin administration (time 0), and every 15 minutes for 60 minutes. Aspirin was administered intragastrically at a dose of 50 mg/ kg. In some experiments, rats were pretreated intragastrically with NaHS (100 mol/kg) 30 minutes prior to ASA administration (controls received vehicle at the same time). In other experiments, glibencamide (10 mg/kg) was administered 15 minutes prior to NaHS administration. Leukocyte adhesion was blindly quantified as the number of leukocytes that adhered to the vessel wall for 30 seconds or more along a 100-m venule length. 13 
Analysis of H 2 S Production by Gastric Mucosa
Sulfide concentrations and production by the gastric mucosa were measured as previously described 20, 21 with minor modifications. Briefly, gastric samples (100 -150 mg) were homogenized in 1 mL ice-cold T-PER protein extractor. A tissue sample containing ϳ5-10 mg protein was also lysed in 1 mL ice-cold T-PER protein extractor. Two milliliters of an assay reaction mixture was introduced into the reactor. The mixture contained 10 mmol/L L-cysteine (or N-acetyl-Lcysteine), 2 mmol/L pyridoxal 5=-phosphate, 100 mmol/L potassium phosphate buffer (pH, 7.4), and 10% (wt/vol) liver homogenate or gastric tissue lysate. DL-propargylglycine, 2 mmol/L, was incubated with gastric homogenates for 5 minutes at 37°C prior to the enzyme reaction. Calmodulin and calcium chloride were added to a final reaction mixture at concentrations of 9.6 mol/L and 0.6 mmol/L, respectively. A constant stream of nitrogen was passed through the mixture via gas-inlet capillary. Reactions were initiated by transferring the reactor from ice bath to a 37°C water bath. The stream of nitrogen carried the sulfide acid in the second reactor containing 2 mL sulfide antioxidant buffer (SAOB) solution, consisting of 2 mol/L KOH, 1 mol/L salicylic acid, and 0.22 mol/L ascorbic acid at pH 12.8. After incubating at 37°C for 90 minutes, 1 mL 50% trichloroacetic acid solution was added to the mixture to stop the reaction. The remainder of H 2 S in the mixture was carried out via nitrogen stream by another 30 minutes of incubation at 37°C. The concentration of sulfide in the SAOB solution was measured with a sulfide-sensitive electrode Model 9616 S 2Ϫ /Ag ϩ electrode (Orion Research, Beverly, MA).
Gastric Expression of CSE and CBS
Total RNA was isolated from rat liver and from gastric tissue by using the TRIzol reagent according to manufacturer specifications (Invitrogen, Milan, Italy). RNA was processed directly to cDNA by reverse transcription with Superscript III (Invitrogen). Briefly, 2 g RNA was added to the mixture, which contained DNase I reaction buffer 10X and 1 U DNase I. The mixture was incubated for 15 minutes at room temperature, then 1 L EDTA 25 mmol/L solution was added, and the mixture was incubated at 95°C for 5 minutes. The mixture was incubated at room temperature for 10 minutes and at 42°C for 50 minutes, heated at 95°C for 5 minutes to inactivate the enzyme, and cooled at 4°C. All PCR primers for quantitative and qualitative PCR were designed using software PRIMER3-NEW using published sequence data from the NCBI database. Primers were synthesized by MWG BIOTECH. For rat GAPDH, the sense primer was 5=-ATGACTCTACCCACGGCAAG-3=, and the antisense was 5=-TACTCAGCACCAGCATCACC-3=; for rat CBS, the sense primer was CCAGGACTTGGAGGTACAGC, and the antisense was TCGGCACTGTGTGGTAATGT; for rat CSE, the sense primer was GTATTGAGGCACCAA-CAGGT, and the antisense was GTTGGGTTTGTGGGT-GTTTC; for COX-1, the sense primer was 5=-CGAGGAT-GTCATCAAGGAG-3=, and the antisense was 5=-TCAGTGAGGCTGTGTTAACG-3=; for COX-2, the sense primer was 5=-TCAAGACAGATCAGAAGCGA-3=, and the antisense was 5=-TACCTGAGTGTCTTTGATTG-3=; for rat TNF-␣, the sense primer was CCC CAT TAC TCT GAC CCC TT, and the antisense was AGG CCT GAG ACA TCT TCA GC; for ICAM-1, the sense primer was CAAACGGGAGAT-GAATGG, and the antisense was TGGCGGTAATAGGTG-TAAAT. In control experiments with 3 replicates, no false positives were detected. Amplification reactions contained 2 L cDNA, 12.5 L of the 2X dynamo SYBR Green Qpcr Master Mix, and 0.75 L of each of the specific primers. Primer concentrations in the final volume of 25 L were 300 nmol/L. All reactions were performed in triplicate in an iCycler iQ system (Bio-Rad, Hercules, CA), and the thermal cycling conditions were as follows: 15 minutes at 95°C, followed by 40 cycles of 95°C for 10 seconds, 55°C for 10 seconds, and 72°C for 20 seconds.
Western Blot Analysis of CSE
Tissues were quickly removed from rats and homogenized with a Teflon tissue grinder in ice-cold buffer (100 mmol/L sodium phosphate, [pH 7.8]/1 mmol/L PMSF), and sonicated. The homogenates were centrifuged at 10,900g for 5 minutes at 4°C, and the supernatants were further centrifuged at 17,400g for 20 minutes at 4°C. The resulting supernatants were quickly frozen in liquid nitrogen and stored at Ϫ80°C until use. Tissue samples were solubilized in the SDS-sample buffer, boiled for 5 minutes, separated on a 10% SDS/polyacrylamide gel, and transferred to the nitrocellulose (0.45 mm, Millipore). The CSE protein was detected with anti-CSE antibody 22 at 1:3000 dilution, followed by incubation with horseradish-peroxidase-conjugated anti-rabbit IgG secondary antibody and the ECL Western blotting system (Amersham Biosciences).
Measurement of CSE Activity
CSE activity was assessed by a sensitive method recently reported by Ogasawara et al, 23 with minor modifications. Briefly, CSE catalyses the pyruvate formation from b-chloro-L-alanine. This reaction is terminated by the addition of DL-propargylglycine. The produced pyruvate is oxidized by pyruvate oxidase in the presence of thiamine pyrophosphate and bivalent magnesium to liberate H 2 O 2 .
A leuco dye, N-(carboxymethylamino)-4,4=-bis(dimethylamino)-diphenylamine, is oxidized by H 2 O 2 with peroxidase to produce Bindschedler's green. The reaction was performed in 96-well dishes, and the absorbance of green dye (727 nm) was measured by a microplate reader.
Cloning of Mouse CSE Promoter Region and Construction of Reporter Plasmids
The 182-bp genomic DNA fragment upstream from the transcriptional start site (Ϫ155 to ϩ27), containing canonical TATA and CAAT boxes and the Sp1 site, was isolated by PCR from mouse hepatocyte genomic DNA. 24 Briefly, the cDNA was amplified using 100 ng genomic DNA as template and utilizing Phusion DNA polymerase (FINNzymes, Espoo, Finland) in a 50 L volume reaction containing 1X Phusion reaction buffer, 200 nmol/L dNTPs, and 300 nmol/L each primer. The sequences of the primers used were as follows: CSE-Prom-Fwd (Ϫ155/Ϫ134), 5=-CACTGCTCTGTGCCA-CTGGGAG-3=; CSE-Prom-Rev (ϩ4/ϩ27), 5=-GTAGGAGT-GCGAGGTGTTGCTTTG-3=. The 182-bp fragment was cloned into pCR-BluntII-TOPO (Invitrogen), according to the manufacturer's instructions, and sequenced. For luciferase assays, the reporter plasmid pGL3 (Ϫ155/ϩ27)-CSE-Prom-Luc was constructed by subcloning CSE-Promotor sequence (Ϫ155 to ϩ27) from pCR-BluntII-TOPO into the KpnI and XhoI sites of pGL3-Enhancer vector (Promega). Briefly, the pCRBluntII-TOPO (Ϫ155/ϩ27)-CSE-Prom construct was digested with KpnI and XhoI, and the resulting promoter digestion products were gel purified and cloned into a pGL3 enhancer vector (Promega), digested with KpnI and XhoI, creating the reporter vector pGL3 (-155/ϩ27)-CSE-Promoter. The SP1 response element (5=-GAGGCGGGGC-3=) in the 182-bp fragment was mutated (5=-GATTCGTTGC-3=) into pCR-BluntII-TOPO (Invitrogen) by using QuickChange SiteDirected Mutagenesis Kit (Stratagene), and oligonucleotide GCCACTGGGATTCGGGGCAGGAACGATC, and its complementary oligonucleotide according to the manufacturer's recommendations. The mutated SP1 response element is in capital letters, and the mutations are underlined and in italic letters. The fragment (Ϫ155/ϩ27)-CSE-Prom with SP1 binding site mutated was excised from pCR-BluntII-TOPO with KpnI and XhoI enzymes and subcloned into KpnI and XhoI sites of pGL3-Enhancer vector (Promega) to generate vector pGL3 (Ϫ155/ϩ27)Mutant-CSE-Prom. All constructs were verified by restriction site digestion and sequence analysis.
Cell Culture, Transfection, and Luciferase Assay
For luciferase assay, HEK-293 cells were cultured in DMEM supplemented with 1% penicillin/streptomycin, 1% L-glutamine, and 10% fetal bovine serum (high glucose) (Invitrogen). Cells were grown at 37°C in 5% CO 2 . All the transfections were made using a calcium phosphate coprecipitation method in the presence of 25 mol/L chloroquine as inhibitor for DNA degradation. Transient transfections were performed using 500 ng reporter vector pGL3 (Ϫ155/ϩ27)-CSE-Prom, 200 ng pCMV-␤-gal as internal control for transfection efficiency. The pGEM vector was added to normalize the amounts of DNA transfected in each assay (2.5 g). Thirty-six to 48 hours posttransfection, the cell were stimulated with ASA, indomethacin, ketoprofen, and diclofenac 50 mol/L for 18 hours. All agents were diluted in DMSO, and control cultures received 0.1% DMSO alone. The cells were lysed in 100 L diluted reporter lysis buffer (Promega), and 0.2 L cellular lysate was assayed for luciferase activity using Luciferase Assay System (Promega). Luminescence was measured using an automated luminometer. Luciferase activities were normalized for transfection efficiencies by dividing the relative light units by ␤-galactosidase activity expressed from cotransfected pCMV-␤-gal plasmid. Each datum point is the average of triplicate assays. Each experiment was repeated at least 3 times.
Nuclear Extract Preparation and Electrophoretic Mobility Shift Assay
Preparation of nuclear extracts from control or drugtreated cells was carried out as described previously. 25 The oligonucleotide 5=-CAGAGAGGGGCGGCCCGAGTG-3= was used as probe. The mutant Sp1 oligonucleotide has the sequence 5=-CAGATATCTAGATGATATCGTG-3=. The reaction mixture for EMSA contained 20 mmol/L Tris-HCl, pH 7.6, 1 mmol/L dithiothreitol, 2 mmol/L MgCl 2 , 1 mmol/L EDTA, 10% glycerol, 1% Nonidet P-40, 1 g poly(dI-dC), and 8 -10 g nuclear proteins. Unlabeled wild-type or mutant oligonucleotides or preimmune, Sp1, or Sp3 antibody was added into the reaction mixture and incubated for 10 minutes at room temperature. 32 P-Labeled probe DNA (300,000 cpm) was added, and the binding reaction was allowed to proceed for another 20 minutes. After reaction, mixtures were resolved on 6% polyacrylamide gels at 200 V for 2 hours. Gels were dried and subjected to autoradiography.
Gastric Prostanoid Synthesis
Gastric PGE 2 concentrations were measured according to previously published methods. [13] [14] [15] Unless otherwise stated, 3 hours after the administration of the drugs, gastric specimens taken from ulcerated tissues were snap frozen in liquid nitrogen. Samples were then lysed in 50 mmol/L Tris-HCl (pH 8.4) buffer and finely minced. After the tissues had been washed and resuspended in 1 mL buffer, they were vortexed at room temperature for 1 minute to stimulate PGE 2 production, followed by centrifugation at 10,000g for 15 seconds at 4°C. The amounts of PGE 2 in the resulting supernatants were determined by specific ELISA (Cayman Chemical Company, Ann Arbor, MI) following manufacturer's instructions.
Statistical Analysis
All data are presented as the mean Ϯ SEM. Comparisons of groups of data were performed using a 1-way analysis of variance followed by the Student-Newman-Keuls post hoc test. An associated probability (P value) of less than 5% was considered significant.
Results
The Gastric Mucosa Generates Physiologically Relevant Concentrations of H 2 S As illustrated in Figure 1 , we found that messenger RNA (mRNA) encoding for CBS and CSE, the 2 key enzymes involved in H 2 S formation from Lcysteine, were expressed in the rat gastric mucosa. Moreover, incubating gastric mucosal homogenates with L-cysteine, the natural substrate of CBS and CSE, in the presence of pyridoxal-5-phosphate, an essential cofactor for enzyme activities (see Materials and Methods section), resulted in H 2 S generation ( Figure 1B , n ϭ 6). We found that, in the presence of L-cysteine, the gastric mucosa generated Ӎ150 nmol/L/mg protein/ min of gaseous H 2 S and that this activity was concentration dependently inhibited by addition of DLpropargylglycine, a selective and irreversible inhibitor of CSE ( Figure 1B ; n ϭ 6; P Ͻ .01 vs L-cysteine alone).
Because H 2 S is a vasodilator, 1 we utilized laser Doppler flowmetry to determine whether or not it modulates gastric mucosal blood flow. As illustrated in Figure 1C , administering NaHS (100 mol/kg) IP to rats resulted in a transient reduction of MAP (6.0 Ϯ 1.6 mm Hg 10 minutes after NaHS administration; n ϭ 6; P Ͻ .05 vs control). This effect was associated with a transient, albeit significant, increase in gastric mucosal blood flow (Ӎ20%; n ϭ 6; P Ͻ .05 vs control). Gastric vasodilation caused by NaHS was abrogated by pretreating rats with glibenclamide (10 mg/kg; n ϭ 6; P Ͻ .05 vs H 2 S). In rats given ASA (100 mg/kg), gastric mucosal blood flow was significantly reduced in comparison with control rats (Figure 1D ; n ϭ 7; P Ͻ .05 vs control). However, administration of NaHS (100 mol/kg) reversed the impairment of gastric mucosal blood flow caused by ASA (n ϭ 6, P Ͻ .05 vs rats treated with ASA alone).
H 2 S Protects Against Gastric Mucosal Injury Induced by ASA and NSAIDs
Administration to rats of ASA, indomethacin, ketoprofen, or diclofenac resulted in damage to the gastric mucosa (n ϭ 6 rats per group, P Ͻ .01 vs control). The injury consisted of hemorrhagic erosions, usually linear, running along the crests of rugal folds, and localized primarily in the corpus region of the stomach. Exposure to ASA and NSAIDs resulted in a 2-to 3-fold increase in MPO activity, a measure of granulocyte accumulation in the gastric mucosa, and 4-to 6-fold increase in gastric TNF-␣ and ICAM-1 mRNA, measures of gastric inflammation (n ϭ 6 rats per group, P Ͻ .01 vs control). NSAID administration was also associated with changes in gastric mucosal PGE 2 synthesis, as well as alterations in the expression of prostanoid generating enzymes. Thus, exposure to ASA and NSAIDs reduced gastric PGE 2 synthesis by Ӎ90% and increased gastric expression of COX-2 mRNA by 3-to 5-fold (n ϭ 6 rats per group, P Ͻ .01 vs control). In contrast, no changes in COX-1 mRNA expression were observed. Treating rats with NaHS significantly attenuated the gastric damage caused by NSAIDs. In rats given NaHS (100 mol/kg, IP), the gastric mucosa injury score; MPO activity; and TNF-␣, ICAM-1, LFA-1, and COX-2 mRNA levels were reduced by Ӎ70%-80% in comparison with rats given ASA or NSAIDs alone (n ϭ 6 rats per group, P Ͻ .01 vs ASA and NSAIDs). NaHS administration also attenuated histologic changes (data not shown) induced by ASA. NaHS had no effect on inhibition of gastric PGE 2 synthesis caused by ASA and NSAIDs (n ϭ 6 rats per group, P Ͼ .05). The protection afforded by NaHS was dose dependent: thus, although a dose of 25 mol/kg failed to attenuate the gastric injury caused by ASA (30 mg/kg) , all of the other tested doses effectively reduced the extent of mucosal damage and MPO activity (Figure 3A and 3D ; n ϭ 6 rats per group, P Ͻ .01 vs ASA). Similar to NaHS, treating rats with L-cysteine or N-acetyl-cysteine protected against mucosal damage caused by ASA ( Figure  3B , C, and F; n ϭ 4 rats per group, P Ͻ .01 vs ASA). However, both agents failed to increase mucosal H 2 S levels ( Figure 3E ).
Exposure to ASA and other NSAIDs resulted in a drastic reduction in the ability of gastric mucosa to generate H 2 S (Figure 4 ; n ϭ 6 rats per group, P Ͻ .01 vs ASA). Suppression of H 2 S generation caused by these agents approached 60% (n ϭ 6 rats per group, P Ͻ .01 vs control). By qRT-PCR and Western blot analysis, we found that AS/NSAIDs administration associates with a significant reduction of CSE, but not CBS, expression (Figure 4B-D; n ϭ 6; P Ͻ .01).
Direct Inhibition of CSE Expression by NSAIDs
Computer-assisted analysis of the promoter region of the mouse and human CSE has revealed the presence of a potential Sp1 consensus sequence (5=-GAGGCGGGGC-3=) located within the Ϫ155/ϩ27 region of the mouse CSE promoter. Because a previous study by Ishii et al 24 demonstrated that transfection of HEK-293 cells with a promoter containing this consensus site results in CSE promoter activation, we have taken advantage from this study to generate a pGL3 (Ϫ155/ϩ27)-CSE-Promoter expression vector cloned upstream to luciferase that was used to transfect HEK-293 cells. As shown in Figure 5A , transfection with this promoter resulted in Ӎ60-fold increase in luciferase expression (n ϭ 4; P Ͻ .05 vs cells transfected with the empty vector). Treating cells with indomethacin almost completely abrogated this effect (n ϭ 4; P Ͻ .05 vs cells transfected with pGL3). Similar to indomethacin, ketoprofen and ASA (0.1, 0.1, and 3 mmol/L, respectively) reduced CSE transactivation in this experimental setting (not shown). To investigate whether the Sp1 binding site was involved in CSE regulation, 26 we transfected HEK-293 cells with a vector carrying on a mutated Sp1 binding site ( Figure 5B and C) , and, as shown in Figure 5A , we found that the mutation of the Sp1 consensus site not only reduced the expression of CSE by Ӎ6 fold in comparison with the cells transfected with the intact Sp1 binding site but greatly attenuated inhibition caused by indomethacin (n ϭ 4; P Ͼ .05), indicating that this site regulates either CSE promoter activity as well as sensitivity of CSE to indomethacin. To determine whether inhibition of CSE promoter activity by indomethacin is caused by changes in the interaction between nuclear proteins with the promoter, an EMSA was performed with oligonucleotides corresponding to the region (Ϫ135 to Ϫ125) of the wild-type promoter of CSE. As shown in Figure 5C , we found that NSAID treatment ( Figure 5C, lanes 4 -7) significantly reduced the binding of nuclear proteins to the probes. Our data also show that interaction of nuclear proteins with the Sp-1 probe is sequence specific because the binding could be competed away by an excess of unlabeled wild-type oligonucleotide ( Figure 5C , lane 10) but not by mutant oligonucleotide ( Figure 5C, lane 9) . We next tested whether the nuclear proteins that bind to this region are Sp1-related proteins. As shown in Figure 5C , lane 8, the addition of a Sp1 antibody abrogated the signal. These data suggest that Sp1 is constitutively bound to the Sp1 site located between bp 135 and 125 in the CSE promoter and that this binding is suppressed by NSAIDs. Because Sp1 is a phosphoprotein, 27, 28 we have investigated whether NSAIDs might modulate its phosphorylation status. Control or drugtreated cells were harvested, and Sp1 was immunoprecipitated by an anti-Sp1 antibody. The immunoprecipitates were subjected to SDS-PAGE and probed with antiphosphoserine antibody. As shown in Figure 5D , phosphorylation of Sp1 (n ϭ 3; Figure 5D , lower) but not the total amount of the protein ( Figure 5D , upper) was significantly reduced by incubation with indomethacin, 100 mol/L (n ϭ 4). Because one of the protein kinases that phosphorylates Sp1 is ERK2, 27 ,29,30 we tested whether NSAIDs reduce ERK phosphorylation. As shown in Figure 5E , indomethacin inhibited basal ERK activity (n ϭ 3). Exposure of HEK-293 cells to PD98059, a specific ERK inhibitor, reduced the Sp1 phosphorylation and reduced CSE expression (n ϭ 3; data not shown).
CSE Inhibition Exacerbates Gastric Injury Caused by NSAIDs
Confirming the regulatory role of H 2 S on maintaining gastric mucosal integrity, inhibition of CSE activity with DL-propargylglycine (10 mg/kg) caused a drastic reduction of H 2 S generation and exacerbated the acute mucosal injury caused by oral administration of ASA ( Figure 6 ; n ϭ 6, P Ͻ .05 vs ASA). Furthermore, DL-propargylglycine administration caused a slight, although significant increase in ICAM-1 and LFA-1 expression in the gastric mucosa ( Figure 6 ; n ϭ 6, P Ͻ .05 vs control).
Protection Exerted by H 2 S Involves K ATP Channels
To investigate the possibility K ATP channels were involved in the protection afforded by H 2 S, we treated rats with glibenclamide (10 mg/kg), a K ATP channel blocker, and pinacidil (10 mg/kg), a K ATP opener. As shown in Figure 7 , glibenclamide reversed the protection afforded by NaHS (100 mol/kg) against the acute gastric damage caused by ASA; increased MPO activity; and reversed the attenuation of COX-2, TNF-␣, ICAM-1, and LFA-1 mRNA expression caused by NaHS administration to ASAtreated rats (Figure 7 ; n ϭ 6, P Ͻ .01 vs ASA plus H 2 S). In contrast, administering rats with pinacidil significantly attenuated gastric mucosal injury caused by ASA ( Figure  7A-I) .
Because glibenclamide reversed the down-regulation of adhesion molecules caused by H 2 S, we determined whether H 2 S exerts antiadhesive effects in vivo and whether these effects were reversed by glibenclamide. These experiments were performed using intravital microscopy. In rats treated only with vehicle, an average of 1 or 2 leukocytes (per 100-m vessel length) were adherent to the endothelium of mesenteric venules under basal conditions, and this did not change significantly over the course of the experiment. Intragastric administration of ASA resulted in a progressive increase in the number of leukocytes adhering to the vessel wall, as shown in Figure 8 . Pretreatment with NaHS (100 mol/ kg) completely inhibited leukocyte adherence induced by ASA (n ϭ 5, P Ͻ .05 vs ASA). However, when glibencamide was administered prior to NaHS, the inhibition of ASA-induced leukocyte adherence was abolished (n ϭ 5, P Ͻ .05 vs NaHS plus ASA). As shown in Figure 8B , the inhibitory effect of NaHS on leukocyte adherence induced by ASA was dose dependent (n ϭ 5, P Ͻ .05 vs ASA alone).
Discussion
Here, we show that the gastric mucosa generates H 2 S and that this gaseous mediator plays a physiologic role in regulating gastric mucosal blood flow and leukocyte adherence to the vascular endothelium. In addition, we demonstrated that ASA/NSAIDs reduce H 2 S generation by directly modulating the expression/activity of CSE. Inhibition of H 2 S generation is a new, COXindependent, mechanism of action of NSAIDs.
H 2 S is increasingly recognized as a functionally relevant mediator of a number of physiologic functions in mammalian tissues. H 2 S is mainly generated by the enzymatic breakdown of L-cysteine by 2 pyridoxal-5=-phosphate-dependent enzymes: CBS and CSE. [1] [2] [3] [4] In addition, another, less important, endogenous source of H 2 S 1 is the nonenzymatic reduction of elemental sulfur to H 2 S using reducing equivalents obtained from the oxidation of glucose (see Figure 9 ). Although CBS is mainly expressed in the liver and central nervous system, CSE is found in smooth muscle cells in the cardiovascular system and in the gastrointestinal tract. Here, we have shown that, although both CBS and CSE are expressed by the gastric mucosa, CSE is the main enzyme involved in the H 2 S generation in the stomach. Consistent with this concept, exposure of gastric mucosal homogenates to the DL-propargylglycine, a selective and irreversible inhibitor of CSE, inhibits H 2 S formation. Generation of H 2 S by the gastric mucosa depends on the presence of pyridoxal-5=-phosphate but not calmodulin, an essential cofactor for CBS, 21 further highlighting the predominant role of this enzyme in the gastric mucosa.
The gastric mucosal blood flow, an essential factor in maintaining gastric mucosal integrity, is regulated by gaseous mediators. [31] [32] [33] [34] [35] NO, the best characterized of these agents, increases mucosal blood flow, whereas inhibition of NO formation with selective and nonselective NO synthase (NOSs) inhibitors exacerbates the mucosal injury caused by NSAIDs. 33 We now provide evidence that H 2 S increases gastric mucosal blood flow. Thus, administering NaHS to rats causes a transient fall in MAP (Ӎ10 mm Hg) while increasing gastric mucosal blood flow by Ӎ20%. 6 The systemic effects of H 2 S are consistent with the finding that CSE is expressed in the aorta and mesenteric artery 6 and that exposure of these vessels to physiologically relevant concentrations of H 2 S (IC 50 ϭ 125 mol/L) results in vasorelaxation. 4 Vasodilation caused by H 2 S is reversed by glibenclamide but is maintained after removal of the endothelium, 4 suggesting that K ATP channels are the targets of this effect.
Several of our results are consistent with the view that protection afforded by H 2 S against the acute gastric injury caused by ASA/NSAIDs is mediated by modulation of adhesive interactions at the endothelium-leukocyte interface. First, NaHS protects against the reduction of mucosal blood flow caused by ASA. Exposure to ASA reduced mucosal blood flow by Ӎ20%, 32 an effect that was reversed by NaHS. Second, H 2 S reduced leukocyte margination into the gastric microcirculation, as measured by MPO activity, and protected against up-regulation of TNF-␣, ICAM-1, and LFA-1. 35, 36 In addition, exposure to H 2 S dose dependently inhibited adherence of leukocytes to the vascular endothelium of mesenteric venules. Because NSAID-induced leukocyte adherence depends on regulation of ICAM-1 on endothelial cells and LFA-1 on leukocytes, 35, 36 these data add to the concept that H 2 S acts locally at the leukocyte/endothelium interface. Third, the finding that anti-adhesive effects of H 2 S were reversed by glibencamide, a K ATP blocker, whereas pinacidil, a K ATP opener, protects against mucosal injury caused by ASA, supports the hypothesis that H 2 S activates K ATP channels.
An important finding of this study is the demonstration that exposure of gastric mucosa to ASA or to NSAIDs selectively decreases H 2 S production by modulating CSE expression while having no effect on CBS expression. The effect on H 2 S production was most profound with indomethacin, which reduced CSE activity/ expression by approximately 80%, but was also observed in rats exposed to ASA, ketoprofen, and diclofenac.
The human and rodent CSE gene has recently been cloned. 24 The core promoter of the gene, located in the 5=-flanking region proximal to the transcriptional start site contains several putative transcriptional factor-binding sites, including MZF-1 and Sp1. 24 Sp1, a member of the Sp/krüppel-like factor family, 37 is a ubiquitously expressed transcription factor that recognizes GC-rich sequences present in regulatory sequences of numerous housekeeping genes and is a known target for NSAIDs. 27 Previous studies have shown that Sp1 DNA binding activity is attenuated by NSAID treatment through a mechanism that involves inhibition of ERK phosphorylation. 27 Here, we demonstrated that Sp1 is a crucial transactivator for CSE gene expression because transfection of HEK-293 cells with a CSE promoter containing the Sp1 binding site stimulated CSE promoter activity, 24 whereas its mutation almost completely abrogated the ability of the promoter to induce CSE expression. Our results also provide evidence that NSAIDs suppress CSE expression via inhibition of the ERK/Sp1 signalling pathway. The DNA binding and transactivation activity of Sp1 is regulated by posttranslational modification (such as phosphorylation and glycosylation) (see Black et al 37 for review). Because Sp1 DNA binding activity, but not the protein level, was attenuated after NSAID treatment, we speculated that an NSAID may modulate a specific intracellular signalling pathway to affect Sp1 function. Consistent with this view, we demonstrated that blockade of CSE expression by NSAIDs correlated with inhibition of ERK activity.
The ability of NSAIDs to regulate Sp1 phosphorylation might also help to explain COX-independent activities of ASA and NSAIDs. Abnormal Sp1 expression and activation have been observed in several human cancers including human hepatocellular carcinoma, 38 gastric carcinoma, 39 -41 and pancreatic adenocarcinoma. 38 Elevated Figure 8 . (A) Intragastric administration of ASA (50 mg/kg) increases leukocyte adherence to the vascular endothelium in mesenteric postcapillary venules. Cotreatment with NaHS (100 mol/kg) attenuates ASA-induced leukocyte adherence. This effect was reversed by glibencamide, a K ATP channel blocker. Data are expressed as mean Ϯ SEM of 6 rats. *P Ͻ .05 vs vehicle of rats treated with ASA alone. (B) NaHS inhibits ASA-induced leukocyte adherence to mesenteric postcapillary venules in a dose-dependent manner. Data are expressed as mean Ϯ SEM of 6 rats. *P Ͻ .05 vs vehicle of rats treated with ASA alone. Figure 9 . Role of H 2 S in gastric mucosal protection. The scheme shows the major biochemical pathways involved in H 2 S generation in mammalians. Both the enzymatic pathway and nonenzymatic pathway of H 2 S generation are shown. The enzymatic pathway is largely prevalent. DL-propargylglycine is a direct inhibitor of CSE activity. Glibenclamide is a K ATP channel blocker. Pinacidil is a K ATP channel opener. Glibenclamide and pinacidil exert divergent effects on gastric protection induced by H 2 S. ASA and NSAIDs inhibit CSE expression/activity. MAT, methionine adenosyltransferase; GNMT, glycine N-methyltransferase; MTs, methyltransferases; CGS, ␥-glutamyl-cysteine synthetase. Inset: Mechanism of CSE inhibition caused by ASA/NASIDs. ASA/NSAIDs inhibit the ERK-dependent phosphorylation of Sp1, a key regulatory mediator of CSE gene expression.
Sp1 expression has also been shown to be correlated with malignancy and reduced survival of patients with gastric cancer. 41, 42 Because the CSE/H 2 S pathway is also involved in regulating neoplastic growth, 43 our data suggest that inhibition of H 2 S formation might contribute to the anticancer activity of ASA and NSAIDs.
Glibenclamide reversed the protection afforded by H 2 S against the mucosal injury caused by ASA. Previous studies have shown that glibenclamide antagonized the protective effect of 16,16-dimethyl-PGE 2 on ethanolinduced gastric injury and exacerbated the mucosal injury induced by gastric perfusion with acidified ethanol, whereas pinacidil reverses the mucosal injury, suggesting that K ATP channels mediate key steps in gastric mucosal homeostasis. 44, 45 Similar to NaHS, L-cysteine and N-acethyl-cysteine were also effective in reducing gastric injury caused by ASA and NSAIDs. However, because these agents failed to increase gastric mucosal concentrations of H 2 S, it appears that protection afforded by L-cysteine and Nacetyl-cysteine is H 2 S independent. Indeed, in addition to release of H 2 S, L-cysteine and N-acetyl-cysteine act as free-radical scavengers. 46 In conclusion, we have shown that H 2 S regulates gastric mucosal blood flow and leukocyte adherence to the endothelium. These effects are likely mediated by K ATP channels. Exposure to ASA/NSAIDs inhibits gastric expression/activity of CSE, a key enzyme for H 2 S synthesis. By promoter deletion and mutation analysis, we demonstrated that NSAIDs act via the Sp1 transcription factor-binding site in the CSE promoter to suppress CSE gene expression. Together, these data establish a role for H 2 S in gastric protection and identify CSE as a novel target for ASA/NSAIDs.
